NCLAT Adjourns Alps Pharmaceuticals Insolvency Appeal

The National Company Law Appellate Tribunal (NCLAT) adjourned an appeal in the Alps Pharmaceuticals insolvency case to April 8, 2026.
The appeal challenges the successful resolution plan for Alps Pharmaceuticals Pvt. Ltd. submitted by the resolution applicant.
The appellant is the Chairman of the Managing Committee of Alps Pharmaceuticals, and the respondents are the successful resolution applicant.